NOVEL THERAPEUTIC USE OF A PHARMACEUTICAL COMPOSITION FOR THE REDUCTION OF THE NUMBER OF ABERRANT CRYPT FOCI AND FOR THE PREVENTION OF COLON CANCER

摘要

The present invention relates to the use of a pharmaceutical composition comprising pharmaceutically accepted additives and Plantago ovata seed husk, rich in mucilages, for the preparation of a medicament for the reduction of the number of Aberrant Crypt Foci (ACF) in the colon of patients diagnosed with intestinal polyps and for the prevention of colon cancer.